Antonin Schmitt

17PUBLICATIONS
22CO-AUTHORS
Biomolecular modelling and designPharmacogenomicsHaematological tumoursMolecular targetsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 17, 2026
PK and PK/PD Modeling of Bcl2 Inhibitor S65487 in Patients With AML and Investigation of Nonlinearity With Microdosing.

|Jun 12, 2026
Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokinetics.

|Sep 16, 2025
Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi method.

Ophélie Cassuto, Romain Mathieu, Carole Helissey

|Apr 26, 2024
Improving olaparib exposure to optimize adverse effects management.

Marylise Sterlé, Alicja Puszkiel, Chloé Burlot

|Jan 12, 2023
Pharmacokinetics and Pharmacodynamic of Alpelisib.

Bernard Royer, Courèche Guillaume Kaderbhaï, Antonin Schmitt

|Sep 15, 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.

Maud Maillard, Manon Launay, Bernard Royer

Pageof 3

Frequent Collaborators

2 joint publications

Bernard Royer

2 joint publications

Marylise Sterlé

2 joint publications

Chloé Burlot

1 joint publications

Pauline Macaire